Main Session
Sep
28
SS 12 - Sarcoma 1: From Margins to Mainstream: Advances in our Understanding of Rare Bone, Cutaneous, and Connective Tissue Tumors
174 - Long-Term Failure Patterns and Prognostic Factors in a Randomized Dose-Escalation Trial for Skull Base Chordomas: A Secondary Analysis from PROG 85-26.
Presenter(s)
Myrsini Ioakeim-Ioannidou, MD - Massachusetts General Hospital, Boston, MA